Intraperitoneal application of chemotherapy in cervical cancer
10.3760/cma.j.issn.1008-6706.2012.02.020
- VernacularTitle:顺铂腹腔灌注联合热化疗治疗宫颈癌
- Author:
Yaqi LI
;
Xun GONG
;
Lianying LUO
;
Yan MA
;
Yu ZHANG
;
Weiting YANG
;
Zhongxiu WU
;
Guofang LIAO
- Publication Type:Journal Article
- Keywords:
Cervix neoplasms;
Intraperitoneal chemotherapy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(2):203-204
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy and toxicity of intraperitoneal chemotherapy combined with intravenous chemotherapy in treatment of cervical cancer.Methods The experimental group of 40 patients received systemic chemotherapy of docetaxel and cisplatin combined abdominal intraperitoneal high-frequency hyperthermia in the control group,40 patients received docetaxel plus cisplatin chemotherapy,The efficacy and toxicity were observed.Results The complete remission rate of observotion group was 82.5％,significantly higher than 62.5％ in control group.Effective rate in observation group was 92.5％ and also significantly higher than 75.0％ in control gronp.After 6 cycles of chemotherapy,the improvement of the experimental group was 85.0％ higher than 57.5 ％ in control gronp.The differemles between the two groups was statistically significant(P ＜ 0.05); the main side effects during chemotherapy are gastrointestinal reactions,since the cells decreased,hair loss,the difference was not statistically significant(P ＞0.05).Conclusion The chemotherapy of docetaxel and cisplatin intraperitoneal chemotherapy can significantly improve the treatment of cervical cancer,without increasing side effects.
